Cullinan Therapeutics Analyst Ratings
Cullinan Therapeutics Analyst Ratings
HC Wainwright Adjusts Price Target on Cullinan Oncology to $28 From $29, Maintains Buy Rating
Cullinan Therapeutics Analyst Ratings
Cullinan Therapeutics Analyst Ratings
Cullinan Oncology Analyst Ratings
Cullinan Oncology Analyst Ratings
Cullinan Oncology Analyst Ratings
Cullinan Oncology Analyst Ratings
Cullinan Oncology Analyst Ratings
JonesTrading Initiates Coverage On Cullinan Oncology With Buy Rating, Announces Price Target of $22
Cullinan Oncology Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34
Cullinan Oncology Analyst Ratings
Cullinan Oncology Analyst Ratings
Analyst Ratings for Cullinan Oncology
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $49 Price Target
HC Wainwright Adjusts Price Target on Cullinan Oncology to $49 From $50, Maintains Buy Rating
No Data